Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin plus rifampicin for MRSA pneumonia
KCT0000029Phase 3Recruiting
- Sponsor
- Asan Medical Center
- Start
- Aug 2010
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin, rifampicin, sponsored by Asan Medical Center. Started Aug 2010; status: recruiting.
02
Drugs
vancomycinrifampicin
Beyond the preview
Go deeper on KCT0000029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000029.